Attached files

file filename
8-K - 8-K - ADVISORY BOARD COd622689d8k.htm

Exhibit 99.1

 

LOGO

 

Contact:  

Michael Kirshbaum

Chief Financial Officer

202.266.5876

jacobsg@advisory.com

     The Advisory Board Company

2445 M Street, N.W.

Washington, D.C. 20037

www.advisory.com

  

THE ADVISORY BOARD COMPANY REPORTS

RESULTS FOR QUARTER ENDED SEPTEMBER 30, 2013

Company Reports Quarterly Revenue Growth of 16%, Contract Value of $491 Million,

and Announces Acquisition of Care Team Connect, Inc.

WASHINGTON, D.C. — (November 4, 2013) — The Advisory Board Company (NASDAQ: ABCO) today announced financial results for the quarter ended September 30, 2013, which is the second quarter of its 2014 fiscal year. Revenue for the quarter increased 16% to $128.3 million, from $110.8 million for the quarter ended September 30, 2012. Contract value increased 13% to $491.3 million as of September 30, 2013, up from $435.1 million as of September 30, 2012. For the quarter ended September 30, 2013, net income attributable to common stockholders was $9.0 million, or $0.24 per diluted share, compared to net income attributable to common stockholders of $7.5 million, or $0.21 per diluted share, for the quarter ended September 30, 2012. For the quarter ended September 30, 2013, adjusted EBITDA was $22.3 million, up from $20.8 million for the quarter ended September 30, 2012. Adjusted net income for the quarter ended September 30, 2013 was $11.4 million, or $0.31 per diluted share, compared to $11.4 million, or $0.31 per diluted share, for the quarter ended September 30, 2012. Adjusted EBITDA, adjusted net income, and non-GAAP earnings per diluted share are all non-GAAP financial measures.

For the six months ended September 30, 2013, revenue increased 17% to $251.6 million, from $214.9 million for the six months ended September 30, 2012. Net income attributable to common stockholders was $12.7 million, or $0.35 per diluted share, for the six months ended September 30, 2013, compared to net income attributable to common stockholders of $11.3 million, or $0.31 per diluted share, for the same period in the prior fiscal year. For the six months ended September 30, 2013, adjusted EBITDA was $44.8 million, up from $40.9 million for the six months ended September 30, 2012. Adjusted net income for the six months ended September 30, 2013 was $22.7 million, or $0.62 per diluted share, compared to $22.5 million, or $0.62 per diluted share, for the six months ended September 30, 2012.

Robert Musslewhite, Chief Executive Officer of The Advisory Board Company, commented, “We are pleased with our strong revenue and earnings growth for the quarter. In markets experiencing tremendous change and transformation, our continuing growth indicates the impact we are having on our members’ most important challenges. As we progress through the important December quarter, across all areas of the business, everyone is fully focused on driving outstanding value for our members and flawless execution.”

Acquisition of Care Team Connect, Inc. and Launch of New Program

The Company announced the acquisition as of October 8, 2013 of Care Team Connect, Inc., a leading provider of comprehensive care management workflow solutions and analytics. The transaction enhances The Advisory Board Company’s existing suite of population health technologies and service offerings and affirms the Company’s position as a leader in the care management market.


Robert Musslewhite commented, “We are excited to add Care Team Connect’s outstanding care management technology and exceptional talent to the Advisory Board’s portfolio of solutions, particularly given our members’ need for effective population health capabilities in the current health care environment. These new tools will supplement our strong portfolio, and, in particular, are a great addition to our Crimson suite of clinical programs. This provider-oriented workflow tool for care management allows the Advisory Board to offer a more comprehensive array of research, technology, and services to help members with all aspects of population health management.”

Mr. Musslewhite continued, “I am excited that we will be bringing this technology to the market without delay. As such, I am pleased to announce today the launch of our newest program, Crimson Care Management, which leverages Care Team Connect’s technology to serve hospitals and health systems seeking to implement a care management workflow tool to build their population health management capabilities. We are optimistic about the impact that this new program will have for our members, particularly given Care Team Connect’s strong relationships with its clients, which include MissionPoint Health Partners in Nashville, Tennessee; Michigan Pioneer ACO in Southfield, Michigan; MemorialCare in Fountain Valley, California; and Integrated Health Partners in Battle Creek, Michigan.”

Care Team Connect’s Chief Executive Officer and founder Ben Albert added, “All of us at Care Team Connect are thrilled to join forces with The Advisory Board Company to continue to build a powerful portfolio for population health management. Given the Advisory Board’s deep knowledge base of best practices, powerful Crimson platform and outstanding member network, I am confident that being a part of this exceptional organization will permit Care Team Connect to have even greater impact on health care delivery in the United States.”

Mr. Musslewhite concluded, “We are pleased to welcome Care Team Connect’s talented staff to The Advisory Board Company. They have exceptional experience and expertise, and the company’s values, service ethic, and outstanding client relationships are a great fit with our own. I am very excited about this infusion of talent and capabilities, and I look forward to our collective success.”

Outlook for Calendar Year 2013

The Company reaffirmed its previously announced calendar year 2013 guidance for revenue, adjusted EBITDA, and non-GAAP earnings per diluted share. For calendar year 2013, the Company expects revenue to be in a range of approximately $500 million to $505 million, adjusted EBITDA to be in a range of approximately $87.5 million to $92.5 million, and non-GAAP earnings per diluted share to be in a range of approximately $1.15 to $1.25. For calendar year 2013, the Company expects share-based compensation expense to be approximately $17.5 million, and amortization of acquisition-related intangible assets to be in a range of $7 million to $8 million. For fiscal year 2014, the Company expects an effective tax rate in a range of approximately 38% to 39%. The Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2013 contains information on the calculation of adjusted EBITDA and non-GAAP earnings per diluted share.

Non-GAAP Financial Measures

This press release and the accompanying tables present information about the Company’s adjusted EBITDA, adjusted net income, and non-GAAP earnings per diluted share, which are non-GAAP financial measures provided as a complement to the results provided in accordance with accounting principles generally accepted in the United States of America (“GAAP”). The term “adjusted EBITDA” for the three and six months ended September 30, 2013 and 2012 refers to net income attributable to common stockholders before adjustment for the items set forth in the first table. The term “adjusted net income” for the three and six months ended September 30, 2013 and 2012 refers to net income attributable to common stockholders excluding the net of tax effect of the items set forth in the second table below. The term “non-GAAP earnings per diluted share” for the three and six months ended September 30, 2013 and 2012 refers to earnings per diluted share excluding the net of tax effect of the items set forth in the third table below.

A reconciliation of the foregoing historical non-GAAP financial measures to the most directly comparable historical GAAP financial measures is provided below for each of the periods indicated. It is not practicable to provide a reconciliation of forecasted adjusted EBITDA or non-GAAP earnings per diluted share to the most directly comparable GAAP financial measures because certain items required for the forecast of such GAAP financial measures, including fair value adjustments to acquisition-related earn-out liabilities, equity in loss of unconsolidated entity, and gains and losses on investment in common stock warrants, cannot reasonably be estimated or predicted at this time.


     Three Months Ended     Six Months Ended  
     September 30,     September 30,  
     2013     2012     2013     2012  

Net income attributable to common stockholders

   $ 9,002      $ 7,481      $ 12,695      $ 11,322   

Equity in loss of unconsolidated entity

     (1,326     592        1,907        2,716   

Provision for income taxes from continuing operations

     4,805        4,944        9,140        8,646   

Other income, net

     (1,091     (688     (1,614     (1,264

Depreciation and amortization

     6,886        4,430        13,240        8,516   

Acquisition and similar transaction charges

     573        599        573        599   

Fair value adjustments to acquisition-related earn-out liabilities

     (950     —          (250     3,500   

Share-based compensation expense

     4,407        3,405        9,066        6,911   
  

 

 

   

 

 

   

 

 

   

 

 

 

Adjusted EBITDA

   $ 22,306      $ 20,763      $ 44,757      $ 40,946   
  

 

 

   

 

 

   

 

 

   

 

 

 
     Three Months Ended     Six Months Ended  
     September 30,     September 30,  
     2013     2012     2013     2012  

Net income attributable to common stockholders

   $ 9,002      $ 7,481      $ 12,695      $ 11,322   

Equity in loss of unconsolidated entity

     (1,326     592        1,907        2,716   

Amortization of acquisition-related intangibles, net of tax

     1,231        790        2,367        1,581   

Acquisition and similar transaction charges, net of tax

     352        370        352        370   

Fair value adjustments to acquisition-related earn-out liabilities, net of tax

     (584     —          (154     2,160   

Loss on investment in common stock warrants, net of tax

     —          68        —          68   

Share-based compensation expense, net of tax

     2,710        2,101        5,576        4,264   
  

 

 

   

 

 

   

 

 

   

 

 

 

Adjusted net income

   $ 11,385      $ 11,402      $ 22,743      $ 22,481   
  

 

 

   

 

 

   

 

 

   

 

 

 
     Three Months Ended     Six Months Ended  
     September 30,     September 30,  
     2013     2012     2013     2012  

GAAP earnings per diluted share

   $ 0.24      $ 0.21      $ 0.35      $ 0.31   

Equity in loss of unconsolidated entity

     (0.03     0.01        0.05        0.08   

Amortization of acquisition-related intangibles, net of tax

     0.03        0.02        0.06        0.04   

Acquisition and similar transaction charges, net of tax

     0.01        0.01        0.01        0.01   

Fair value adjustments to acquisition-related earn-out liabilities, net of tax

     (0.02     —          —          0.06   

Loss on investment in common stock warrants, net of tax

     —          —          —          —     

Share-based compensation expense, net of tax

     0.08        0.06        0.15        0.12   
  

 

 

   

 

 

   

 

 

   

 

 

 

Non-GAAP earnings per diluted share

   $ 0.31      $ 0.31      $ 0.62      $ 0.62   
  

 

 

   

 

 

   

 

 

   

 

 

 


Web and Conference Call Information

As previously announced, the Company will hold a conference call to discuss its second quarter performance this evening, November 4, 2013, at 5:30 p.m. Eastern Time. The conference call will be available via live webcast on the Company’s website at www.advisory.com/IR. To participate by telephone, the dial-in number is 888.317.6016. Participants are advised to dial in at least five minutes prior to the call to register. The webcast will be archived for seven days from 8:00 p.m. Eastern Time on Monday, November 4, until 11:00 p.m. Eastern Time on Monday, November 11, 2013.

About The Advisory Board Company

The Advisory Board Company is a global research, technology, and consulting firm partnering with 165,000 leaders in 4,100 organizations across health care and higher education. Through its innovative membership model, the Company collaborates with executives and their teams to elevate performance and solve their most pressing challenges. The Company provides strategic guidance, actionable insights, web-based software solutions, and comprehensive implementation and management services. For more information, visit the firm’s website, www.advisory.com.

Forward-Looking Statements

This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements, including the Company’s expectations regarding its revenue, adjusted EBITDA, non-GAAP earnings per diluted share, share-based compensation expense, amortization of acquisition-related intangibles, and effective tax rate for calendar year 2013 are based on information available to the Company as of November 4, 2013, the date of this news release, as well as the Company’s current projections, forecasts, and assumptions, and are subject to risks and uncertainties. You are hereby cautioned that these statements may be affected by certain factors, including those set forth below. Consequently, actual operations and results may differ materially from the results discussed or implied in the forward-looking statements, and reported results should not be considered as an indication of future performance. Factors that could cause actual results to differ materially from those indicated or implied by the forward-looking statements include, among others, changes in the financial condition of the health care industry, our dependence on renewal of membership-based services, the need to attract new business and retain current members and qualified personnel, new product development, competition, risks associated with the Company’s software tools and management and advisory services, risks relating to privacy, information security, and other health care-related laws and standards, maintaining our third-party provider relationships and strategic alliances, our ability to license technology from third parties, impairment of goodwill, and various factors related to income and other taxes, as well as other risks and uncertainties described in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2013, which is available for review on the Company’s website at www.advisory.com/IR and at the Securities and Exchange Commission’s website at www.sec.gov. Additional information will also be set forth in the Company’s Report on Form 10-Q for the quarter ended September 30, 2013, which will be filed with the Securities and Exchange Commission in November 2013.

Accordingly, readers are cautioned not to place undue reliance on the forward-looking statements made in this news release, which speak only as of the date of this news release. The Company does not undertake to update any of its forward-looking statements, whether as a result of circumstances or events that arise after the date they are made, new information, or otherwise.

# # #


THE ADVISORY BOARD COMPANY

UNAUDITED CONSOLIDATED STATEMENTS OF INCOME

AND OTHER OPERATING STATISTICS

(In thousands, except per share data)

 

     Three Months Ended     Selected     Six Months Ended     Selected  
     September 30,     Growth     September 30,     Growth  
     2013     2012     Rates     2013     2012     Rates  

Statements of Income

            

Revenue

   $ 128,341      $ 110,758        15.9   $ 251,557      $ 214,900        17.1
  

 

 

   

 

 

     

 

 

   

 

 

   

Cost of services, excluding depreciation and amortization (1) (2)

     69,857        56,989          135,807        115,355     

Member relations and marketing (1)

     22,198        21,486          44,386        40,606     

General and administrative (1) (3)

     18,010        15,632          35,996        29,111     

Depreciation and amortization (4)

     6,886        4,430          13,240        8,516     
  

 

 

   

 

 

     

 

 

   

 

 

   

Operating income (5)

     11,390        12,221          22,128        21,312     

Other income, net

     1,091        688          1,614        1,264     
  

 

 

   

 

 

     

 

 

   

 

 

   

Income before provision for income taxes and equity in loss of unconsolidated entities

     12,481        12,909          23,742        22,576     

Provision for income taxes

     (4,805     (4,944       (9,140     (8,646  

Equity in loss of unconsolidated entities (6)

     1,326        (592       (1,907     (2,716  
  

 

 

   

 

 

     

 

 

   

 

 

   

Net income before allocation to noncontrolling interest

     9,002        7,373          12,695        11,214     

Net loss attributable to noncontrolling interest

     —          108          —          108     
  

 

 

   

 

 

     

 

 

   

 

 

   

Net income attributable to common stockholders

   $ 9,002      $ 7,481        20.3   $ 12,695      $ 11,322        12.1
  

 

 

   

 

 

     

 

 

   

 

 

   

Net income attributable to common stockholders per share

            

Basic

   $ 0.25      $ 0.22        $ 0.36      $ 0.33     

Diluted

   $ 0.24      $ 0.21        14.3   $ 0.35      $ 0.31        12.9

Weighted average common shares outstanding

            

Basic

     35,883        34,660          35,686        34,421     

Diluted

     36,897        36,253          36,758        36,154     

Contract Value (at end of period)

   $ 491,338      $ 435,084        12.9      

Percentages of Revenue

            

Cost of services, excluding depreciation and amortization (1) (2)

     54.4     51.5       54.0     53.7  

Member relations and marketing (1)

     17.3     19.4       17.6     18.9  

General and administrative (1) (3)

     14.0     14.1       14.3     13.5  

Depreciation and amortization (4)

     5.4     4.0       5.3     4.0  

Operating income

     8.9     11.0       8.8     9.9  

Net income attributable to common stockholders

     7.0     6.8       5.0     5.3  

                             

(1)       Amounts include share-based compensation, as follows:

 

  

  

     

Cost of services

     1,284        989                        2,689        1,993                   

Member relations and marketing

     925        658          1,901        1,336     

General and administrative

     2,198        1,758          4,476        3,582     

 

(2)       Amounts include fair value adjustments of acquisition related earn-out liabilities, as follows:

 

  

Cost of services

     (950     —                          (250     3,500                   

 

(3)       Amounts include acquisition and transaction related costs, as follows:

 

  

     

General and administrative

     573        599                        573        599                   

 

(4)       Amounts include amortization of acquisition-related intangibles, as follows:

 

  

     

Depreciation and amortization

     2,001        1,281                        3,848        2,562                   

 

(5)       Amounts include loss on investment in common stock warrants, as follows:

 

  

     

Other income, net

     —          (110                     —          (110                

 

(6) During the quarter ending September 30, 2013, one of the Company’s investments, Evolent Health, completed a reorganization in conjunction with an additional round of equity financing. The Company is working through the final accounting for the transaction and has included its preliminary results in this release.


THE ADVISORY BOARD COMPANY

CONSOLIDATED BALANCE SHEETS

(In thousands)

 

                                                 
     September 30,     March 31,  
     2013     2013  
     (unaudited)        

ASSETS

    

Current assets:

    

Cash and cash equivalents

   $ 73,383      $ 57,829   

Marketable securities, current

     4,501        16,611   

Membership fees receivable, net

     387,805        370,321   

Prepaid expenses and other current assets

     19,976        15,477   

Deferred income taxes, current

     9,928        7,664   
  

 

 

   

 

 

 

Total current assets

     495,593        467,902   

Property and equipment, net

     86,928        71,174   

Intangible assets, net

     31,391        32,381   

Deferred incentive compensation and other charges

     79,460        73,502   

Deferred income taxes, net of current portion

     4,427        3,888   

Marketable securities, net of current portion

     122,309        140,228   

Goodwill

     104,478        95,540   

Investments in unconsolidated entities

     20,000        1,907   

Other non-current assets

     5,550        9,908   
  

 

 

   

 

 

 

Total assets

   $ 950,136      $ 896,430   
  

 

 

   

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

    

Current liabilities:

    

Deferred revenue, current

   $ 405,541      $ 398,541   

Accounts payable and accrued liabilities

     79,692        75,089   

Accrued incentive compensation

     16,111        21,033   
  

 

 

   

 

 

 

Total current liabilities

     501,344        494,663   

Deferred revenue, net of current portion

     123,237        104,484   

Other long-term liabilities

     16,182        15,866   
  

 

 

   

 

 

 

Total liabilities

     640,763        615,013   
  

 

 

   

 

 

 

Redeemable noncontrolling interest

     100        100   

The Advisory Board Company’s stockholders’ equity:

    

Common stock

     360        351   

Additional paid-in capital

     405,483        375,622   

Accumulated deficit

     (94,272     (95,809

Accumulated other comprehensive (loss) income

     (2,190     1,261   
  

 

 

   

 

 

 

Total stockholders’ equity controlling interest

     309,381        281,425   

Equity attributable to noncontrolling interest

     (108     (108
  

 

 

   

 

 

 

Total stockholders’ equity

     309,273        281,317   
  

 

 

   

 

 

 

Total liabilities and stockholders’ equity

   $ 950,136      $ 896,430   
  

 

 

   

 

 

 


THE ADVISORY BOARD COMPANY

UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

 

     Six Months Ended September 30,  
     2013     2012  

Cash flows from operating activities:

    

Net income before allocation to noncontrolling interest

   $ 12,695      $ 11,214   

Adjustments to reconcile net income before allocation to noncontrolling interest to net cash provided by operating activities:

    

Depreciation and amortization

     13,240        8,516   

Deferred income taxes

     (737     (408

Excess tax benefits from stock-based awards

     (12,839     (9,721

Stock-based compensation expense

     9,066        6,911   

Amortization of marketable securities premiums

     1,358        958   

Loss on investment in common stock warrants

     —          110   

Equity in loss of unconsolidated entity

     1,907        2,716   

Changes in operating assets and liabilities:

    

Membership fees receivable

     (16,825     (37,583

Prepaid expenses and other current assets

     8,340        (6,252

Deferred incentive compensation and other charges

     (5,958     (3,958

Deferred revenue

     25,459        57,614   

Accounts payable and accrued liabilities

     6,281        22,456   

Acquisition-related earn-out payments

     (1,812     (1,182

Accrued incentive compensation

     (4,922     (6,524

Other long-term liabilities

     316        (3,976
  

 

 

   

 

 

 

Net cash flows provided by operating activities

     35,569        40,891   
  

 

 

   

 

 

 

Cash flows from investing activities:

    

Purchases of property and equipment

     (23,585     (14,562

Capitalized external use software development costs

     (2,309     (1,723

Investments in and loans to unconsolidated entity

     (15,641     —     

Cash paid for acquisition, net cash acquired

     (11,482     —     

Redemptions of marketable securities

     43,189        23,220   

Purchases of marketable securities

     (19,824     (42,889
  

 

 

   

 

 

 

Net cash flows used in investing activities

     (29,652     (35,954
  

 

 

   

 

 

 

Cash flows from financing activities:

    

Proceeds from issuance of stock from exercise of stock options

     13,497        16,205   

Withholding of shares to satisfy minimum employee tax withholding

     (5,796     (3,844

Proceeds from issuance of stock under employee stock purchase plan

     256        165   

Excess tax benefits from stock-based awards

     12,839        9,721   

Contributions from noncontrolling interest

     —          100   

Purchases of treasury stock

     (11,159     (7,999
  

 

 

   

 

 

 

Net cash flows provided by financing activities

     9,637        14,348   
  

 

 

   

 

 

 

Net increase in cash and cash equivalents

     15,554        19,285   

Cash and cash equivalents, beginning of period

     57,829        60,642   
  

 

 

   

 

 

 

Cash and cash equivalents, end of period

   $ 73,383      $ 79,927